First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - FOURTWENTY PHARMA LIMITED

ANALYSIS
Credit Risk Update: FOURTWENTY PHARMA LIMITED, C/O PM+M NEW CENTURY HOUSE, GREENBANK TECHNOLOGY PARK, CHALLENGE WAY, BLACKBURN, LANCASHIRE, BB1 5QB. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 May 2023. The company was incorporated on 16 May 2018.

The accounts next due date is 28 February 2025. There are no mortgages.

The above was based on public record information as at 10 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 11364478
Date Incorporated: 16 May 2018
Date Latest Accounts: 31 May 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 11364478
Annual Return: Unknown
Registered Office: C/O PM+M NEW CENTURY HOUSE, GREENBANK TECHNOLOGY PARK, CHALLENGE WAY, BLACKBURN, LANCASHIRE, BB1 5QB
SIC Code and Operations: 78300
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

FOURTWENTY PHARMA LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 20 April 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
SC422622 FOURTWENTYSEVEN DESIGN LTD. Active
SC412104 FOURTWENTYSIX LTD Active
13183102 FOURTWENTYSTREET LTD Active - Proposal to Strike off
14533844 FOURTWENTYTWO LEGACY LIMITED Active
12753533 FOURTWO BRICKWORK LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd